Searched for
CHRONIC MEDICINE PORTFOLIO
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...09 Jun, 2026, 01.55 PM IST- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...02 Jun, 2026, 04.41 PM IST
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...31 May, 2026, 01.34 PM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...28 May, 2026, 11.04 PM IST
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...27 May, 2026, 05.30 AM IST
- Kerala’s healthcare gold rush: How private equity is reshaping hospitals and raising fears over costsPrivate equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by inde...24 May, 2026, 07.35 AM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...23 May, 2026, 11.36 AM IST
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...20 May, 2026, 12.18 PM IST
- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...19 May, 2026, 02.10 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST
- RPG Group invests in Rs 4 crore in e-pharmacy MedsOnWayThe investment is part of RPG Group’s strategy to use RPG Ventures to incubate and build new businesses.06 Nov, 2017, 04.34 PM IST
- Demonetisation: People stock up on medicines to get rid of old notesAWACs found that anti-diabetic, cardiovascular and BP drugs have shown a significant increase in sales as compared to corresponding period ...29 Nov, 2016, 12.58 AM IST
- Chronic illness sees a spurt in business opportunity for pharma marketAccording to data from AIOCD, the Indian pharma market has grown at a compound annual growth rate of 3.3% in volume terms in the past five ...19 Nov, 2014, 05.42 AM IST
Load More
